Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Scientific Foundations > Lecture 66 > Flashcards

Lecture 66 Flashcards

Absorption, Bioavailability, Distribution

1
Q

pharmacokinetics: ADME

A
  • absorption, distribution, metabolism, elimination
  • after absorption → free drug is distributed in systemic circulation to receptors, tissue reservoirs,or become protein-bound
  • after distribution → they are metabolized and the metabolites they secrete are excreted
  • sometimes free drug can be directly excreted

pg 1688

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

absorption

A
  • irreversible transfer of a xenobiotic from its site of administration to the systemic circulation (blood)
  • a drug administered via IV = immediate and complete (100%) absorption (but really bypasses absorption), then distributed to other body compartments and eliminated by 1st-order kinetics
  • a drug administered extravascularly must pass through physiological barriers to the blood to be effective (barriers → skin, mucous membranes, GIT, BBB, placenta…)

pg 1689

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

routes of administration

A

based on the mechanism of drug absorption (transport)

pg 1690

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

oral administration (enteral route)

A
  • easily and conveniently self-administered
  • shows the weaknesses in human barrier defenses
  • exposes the drug to harsh acidic (stomach) and basic (intestine) environments → limits absorption and drug must be stable

pg 1690

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

first-pass metabolism

A
  • drug moves to the liver via portal system for detoxification before entering the blood; inactivates a fraction of the drug
  • drugs exhibiting significant first-pass metabolism must be administered in sufficient doses to ensure therapeutic drug concentrations in the blood (or change the route)
  • oral is most convenient, but may have a significant first-pass effect (5 to < 100% bioavailability); rectal has less of a first-pass effect than oral (30 to < 100%)

pg 1691

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

factors affecting GI absorption

A

Drug Factors (properties):

  • size (molecular size and type of dosage form)
  • lipid solubility (hydrophobicity vs hydrophilicity)
  • ionization (strong bases and acids are poorly absorbed)

small size, hydrophobic and neutral drugs cross cell membranes&raquo_space;> large size, hydrophilic or charged drugs, unless they are carried by transporters

Physiological Factors:

  • gut content
  • GIT pH
  • motility
  • generally, little absorption in stomach until drug reaches small intestine (exceptions: buccal, sublingual, or rectal dosage forms)

pg 1692

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

parenteral route of drug administration

A
  • a drug is introduced directly into the systemic circulation
  • rapid onset of action > oral
  • irreversible toxicity when administered too rapidly or in incorrect doses

Examples:

  • subcutaneous (SC) → into poorly vascularized adipose tissue (slow onset, oil-based drugs, small volumes)
  • intramuscular (IM) → well vascularized IM space (immediate onset, oil-based, can affect lab tests)
  • intravenous (IV) → rapid onset, controlled drug delivery
  • intra-arterial (IA)
  • intrathecal (IT) → into cerebrospinal fluid (bybasses BBB)

pg 1693

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

mucous membrane route of drug administration

A
  • highly vascular
  • rapid absorption and onset
  • low incidence of infection
  • convenience of administration

Examples:

  • sublingual → rapidly dissolving tablets
  • ocular and nasal → liquid drops
  • pulmonary → aerosols, gaseous drugs, avoid 1st pass effect, rapid absorption and onset due to high SA (bioavailability 5 to < 100%)
  • rectal → suppositories, decreased 1st pass effect, good for unconscious patients, infants, or in vomiting
  • reproductive tract → suppositories, creams

pg 1694

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

transdermal route of drug administration

A
  • simple and convenient
  • no risk of infection
  • ideal for drugs slowly absorbed and continuously administered
  • for lipophilic drugs
  • bioavailability between 80 and 100%
  • enables passive diffusion across the skin
  • Examples: nicotine, estrogen, scopolamine patches

pg 1695

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Absorption is the reversible transfer of a xenobiotic from its site of administration to the systemic circulation.

A. True
B. False

A

B. False

pg 1696

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A 29-year-old woman is prescribed carbamazepine for trigeminal neuralgia. She has a strong family history of osteoporosis. As a result, the physician also advises her to increase her intake of vitamin D. The most likely reason for this recommendation is that carbamazepine may affect which of the following pharmacokinetic processes?

A. absorption
B. distribution
C. excretion
D. metabolism
E. protein binding

A

D. Metabolism

pg 1697

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

local factors that affect absorption

A
  • large or rapidly administered dose → high local concentration of a drug vs the surrounding tissue → high concentration gradient ΔC
  • high ΔC → drives the distribution of the drug into the nearby tissue and/or vasculature
  • factors decrease ΔC → reduce drug distribution → reduce drug absorption

pg 1698

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

regional factors that affect absorption

A
  • highly perfused region → high absorption and rapid clearance → maintains the drug concentration at a low level (sink condition) in the compartment → maintains ΔC → driving force for absorption
  • ex: volatile general anesthetics (inhalation)
  • lungs are highly perfused, anesthetic is cleared rapidly into the systemic circulation → no dose accumulation in and a ΔC promoting diffusion of anesthetic into the blood is maintained
  • individual with greater body mass → large SA for absorption → large Vd → remove a drug from the site of administration faster → increase the rate and extent of drug absorption

KNOW SINK CONDITION

pg 1699

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

other factors that affect absorption

A

Chemical Properties of Drug:

  • water/lipid solubility
  • ionization of drug

Physical Properties:

  • particle size
  • disintegration time (breakdown of the tablet)
  • dissolution time of drug

pg 1700

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mechanism of absorption

A
  1. passive diffusion (non-carrier mediated)
  2. facilitated diffusion (carrier mediated)
  3. active transport (carrier mediated → against the gradient)

pg 1701

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

passive diffusion

A
  • described mathematically by Fick’s 1st Law
  • rate of diffusion across a membrane (dC/dt) is proportional to the difference in concentration (Ce - Ci)
  • molecules transported across a cell membrane (from a region of higher conc to one of lower conc) → NO energy is consumed
  • used by most relatively small lipophilic molecules and drugs

dC/dt = DA/h × (Ce - Ci)
A = surface area
C-C = concentration gradient
Ce = extracellular gradient
Ci = intracellular gradient
h = thickness of membrane
D = diffusion coefficient of drug across GI membrane

pg 1702

17
Q

Which of the following is correct regarding the process of passive diffusion?

A. It requires a carrier protein molecule.
B. It requires a concentration gradient.
C. It is a saturable process.

A

B. It requires a concentration gradient

pg 1703

18
Q

facilitated diffusion

A
  • NO energy is required
  • higher conc saturates the carrier mechanism → increasing drug does NOT increase the rate of absorption → constant rate of absorption
  • competition between 2 similar molecules for same transfer mechanism inhibits the absorption of one or both molecules
  • plays a very minor role in drug absorption

pg 1704

19
Q

active transport

A
  • molecules transported against the concentration gradient across a cell membrane (from a region of lower conc to one of higher conc)
  • requires ATP
  • ex in SI: peptide, nucleoside, sugar, bile acid, amino acid, and ions

pg 1705

20
Q

bioavailability (F)

A
  • F = rate and extent to which drug is absorbed from a dosage form and becomes available in the blood (at the site of action)
  • F = fraction of drug that reaches the systemic circulation
  • certain drugs are influenced by the presence of food, which can reduce the absorption rate and the max conc (and vice versa)
  • many orally administered drugs undergo first-pass metabolism in the liver
  • drugs with 100% bioavailability → 100% of drug reaches the blood → same for all routes of drug administration
  • if the drug has less than 100% bioavailability, the dose should be increased (to a safe dosage)
  • drugs with similar bioavailability have similar AUC (plasma drug concentration vs time → total amount of drug reaching systemic circulation)
  • rate of absorption = ΔC/Δt

pg 1707-1708

21
Q

Which one of the following routes of administration does not have an absorption phase?

A. subcutaneous
B. intramuscular
C. intravenous
D. sublingual
E. inhalation

A

C. intravenous

pg 1709

22
Q

factors affecting bioavailability

A

bioavailability (F) = quantity of drug reaching systemic circulation ÷ quantity of drug administered (F = mg absorbed/mg dose)

  • chemical-physical properties of the drug
  • route of administration
  • patient-specific factors like transporters and enzymes

pg 1710

23
Q

calculating the oral dose and bioavailability

A
  • bioavailabilityoral = doseIV × bioavailabilityIV ÷ doseoral
  • doseoral = (doseIV × FIV) ÷ Foral

pg 1711

24
Q

A 52-year-old man present to the office for routine follow-up. Currently, he is under treatment for HTN and congestive heart failure with intravenous Vasotec (1.25 mg) and a diuretic. The physician decided to prescribe an oral dose of the same drug, bioavailability = 60%. What will be the value of the oral dose?

A. 2.083
B. 2.58
C. 2.83
D. 3.83
E. 0.83

A

doseoral = doseIV × bioavailabilityIV ÷ bioavailabilityoral

dose = 1.25 mg × (100/100) ÷ (60/100) = 2.083 (A)

pg 1712-1713

25
Q

half-life (t1/2)

A
  • time required for the drug concentration in the plasma to decrease to 1/2 of its original value
  • used to estimate the frequency of dosing required to maintain the plasma concentration of the drug in the therapeutic range
  • because most drugs are eliminated by first-order kinetics, the body is considered as a single compartment with a volume of distribution = Vd
  • concentration at steady state is target for therapeutic window (based on drug dosing and dosing frequency) → take dose so many times at drug t1/2 to reach steady state
  • t1/2 = 0.693/Kel… Kel = K elimination

pg 1714

26
Q

Csteady state

A
  • (bioavailability × dose) ÷ (intervaldosing × clearance)
  • t1/2 = (0.693 × Vd) ÷ Cl
  • a decrease in clearance or increase in Vd = prolonged t1/2 and enhances the effect of the drug on the target

pg 1715

27
Q

factors altering half-life

A
  • physiologic and pathologic changes in Vd and Cl
  • some P450 enzymes are induced by some drugs (carbamazepine and phenytoin) and inhibited by (cimetidine and ciprofloxacin)
  • effects on Vd: aging, obesity, pathologic fluid
  • effects on clearance: cytochrome P450 induction, cytochrome P450 inhibition, cardiac failure, hepatic failure, renal failure

pg 1716

28
Q

A 35-year-old male presents to the clinic for the treatment of an infection. His physician prescribes amoxicillin, which has a volume of distribution of 21 L. If the patient weighs 85 kg and the clearance of the drug is 25 L/hr, what is the elimination half life of the drug?

A. 0.707 hr
B. 0.85 hr
C. 0.58 hr
D. 1.25 hr
E. 0.37 hr

A

Vd = 21 L for ideal body weight (70 kg)
for pt BW of 85 → Vd = 25.5 L

t1/2 = (0.693 × 25.5 L) ÷ (25 L/hr) = 0.707 (A)

pg 1717-1718

29
Q

volume of distribution

A

usually given in reference to someone of ideal body weight (70 kilograms for male)

30
Q

A 39-year-old man comes to the clinic with NYHA class IV congestive heart failure. He states that he is currently taking 250 μg/day of digoxin. The Vd of digoxin is 7.3 L/kg, based on ideal body weight. The patient’s weight is 68 kg. The average half-life is 40 h. The average bioavailability of digoxin is 70%. What is the steady-state concentration of digoxin?

A. 0.848 μg/L
B. 0.814 μg/L
C. 1.848 μg/L
D. 0.085 μg/L

A

Csteady state = [(0.7)(250 μg)]/[(24 h)(Cl)]
Cl = (Vd)(Kel) = (7.3)(68)(Kel)
Kel = 0.693/t1/2 = 0.693/40 h = 0.0173 h-1
Cl = (7.3 L/kg)(68 kg)(0.0173 h-1) = 8.6 L/h
Csteady state = [(0.7)(250 μg)]/[(24 h)(8.6 L/h)] = 0.848 (A)

pg 1719-1720

Scientific Foundations (46 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions